Sherbrooke Park Advisers’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,239
Closed -$1.15M 643
2025
Q2
$1.15M Buy
14,239
+7,753
+120% +$598K 0.5% 28
2025
Q1
$521K Buy
6,486
+2,234
+53% +$186K 0.24% 129
2024
Q4
$348K Buy
+4,252
New +$354K 0.11% 330
2024
Q2
Sell
-5,048
Closed -$374K 1090
2024
Q1
$374K Buy
+5,048
New +$352K 0.07% 476
2023
Q4
Sell
-7,531
Closed -$474K 599
2023
Q3
$474K Buy
+7,531
New +$469K 0.15% 250
2023
Q1
Sell
-7,200
Closed -$521K 270
2022
Q4
$521K Buy
+7,200
New +$516K 0.38% 109

Other funds holding MET

Sherbrooke Park Advisers's MET Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of MetLife (MET) in Q3 2025, closing a stake of 14,239 shares — an estimated $1.15M sold.

Sherbrooke Park Advisers first reported a position in MET in Q4 2022 and held it in 6 quarters. The position peaked at $1.15M in Q2 2025. 1,365 funds tracked by Wall St. Rank hold MET as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 14,239 MetLife shares in Q3 2025, an estimated $1.15M.
  • Sherbrooke Park Advisers first reported a position in MetLife in Q4 2022 and held it in 6 quarters.
  • Sherbrooke Park Advisers's MetLife position peaked at $1.15M in Q2 2025.
  • 1,365 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.